Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:

NCT ID: NCT02735551 Terminated - Contraception Clinical Trials

LARC Forward Contraceptive Counseling at MHCC

Start date: April 2016
Phase: Phase 4
Study type: Interventional

This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college population compared to LARC forward counseling and referral to a secondary clinic for LARC placement. The study will be conducted at Mount Hood Community College (MHCC) in Oregon. Participants will be enrolled into three groups. All groups will receive the same standardized contraceptive counseling ("LARC forward counseling") and participants will be able to choose between a LARC method and short-acting method of birth control.

NCT ID: NCT02734199 Completed - Contraception Clinical Trials

HER Salt Lake Initiative

HER-SL
Start date: November 2014
Phase:
Study type: Observational

This study aims to understand the long-term health, social, and economic impacts of transitioning a community to Highly Effective Reversible Contraception (HER-C).

NCT ID: NCT02733081 Withdrawn - Contraception Clinical Trials

Simplified IUD Insertion Technique

SIIT
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This is a randomized controlled trial that compares traditional IUD insertion with that of a no uterine sound, no bimanual pelvic exam approach. The investigators hypothesis is that IUD placement is safe and effective without pre-procedural assessment of uterine size, direction, or depth.

NCT ID: NCT02732418 Completed - Contraception Clinical Trials

Lower Dose Depo Provera® Contraceptive Injection

Start date: December 2, 2016
Phase: Phase 1
Study type: Interventional

This is a randomized, partially-blinded, multi-center, parallel-group study to evaluate and compare the PD and PK of MPA after a single SC injection of either 45 mg/0.3 mL, 75 mg/0.5 mL or 105 mg/0.7 mL of Depo-Provera CI, and one cycle of Depo-subQ 104 use when injected in the abdomen, in women of reproductive age with confirmed ovulatory baseline cycle

NCT ID: NCT02722421 Completed - HIV Clinical Trials

Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women

Start date: April 6, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether increasing the dose of the levonorgestrel subdermal contraceptive implant will overcome a detrimental drug-drug interaction with efavirenz based antiretroviral therapy.

NCT ID: NCT02720224 Completed - Contraception Clinical Trials

Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol

Start date: February 2016
Phase: Phase 1
Study type: Interventional

This study is being conducted to further understand the elimination pathways, metabolite profile and pharmacokinetic (PK) profile of carbon 14 labelled estetrol ([14C] estetrol).

NCT ID: NCT02718222 Completed - Contraception Clinical Trials

Impact and Performance of Institutionalizing Immediate Post-partum IUD Services

Start date: September 2015
Phase: N/A
Study type: Interventional

Studying the impact and performance of institutionalizing immediate post-partum IUD services as a routine part of antenatal counselling and delivery room services in Sri Lanka, Tanzania, and Nepal.

NCT ID: NCT02714686 Active, not recruiting - Contraception Clinical Trials

Evaluation of a Mass Media Family Planning Campaign on the Uptake of Contraceptive Methods in Burkina Faso

Start date: April 2016
Phase: N/A
Study type: Interventional

In this experiment, the investigators will study the effect of a mass media family planning campaign on contraception related behavior. The study takes place in Burkina Faso, a country with an average of six children born to each woman, and a modern contraceptive prevalence rate (mCPR) estimated at 15% in 2010 at the national level, as per the Demographic Health Survey (DHS) 2010 report on Burkina Faso. The aim of this study is to provide robust evidence on the efficiency and cost-effectiveness of an intense three-year mass media campaign focused on family planning. The campaign will diffuse messages about the financial and health benefits of family planning, and information on the different types, sources, advantages, and disadvantages of different contraceptive methods. The study will target women at the age of reproduction in rural areas of Burkina Faso to measure the effect of the intervention on total and modern contraceptive prevalence rates, perceptions of family planning, contraception-related behavior, and general gender norms. Burkina Faso is an ideal place to evaluate the impact of a radio campaign because a high percentage of the rural population listens to local radio which is in the local language. Radio station areas are distinct because they target very local languages and their reach is limited by government decree, which allows for the implementation of a randomized control trial.

NCT ID: NCT02710708 Completed - Contraception Clinical Trials

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Start date: May 27, 2016
Phase: Phase 4
Study type: Interventional

The primary objective is to assess the safety profile of YAZ in Chinese women, including adverse drug reactions (ADRs). The secondary objectives are to investigate the rate of unintended pregnancies, the cycle control for subjects with and without preceding abortion, the bleeding pattern of subjects with and without preceding abortion (including the abortion-related bleeding pattern) and the efficacy in moderate acne vulgaris. Another objective is to investigate the effect on dysmenorrhea.

NCT ID: NCT02694627 Completed - Contraception Clinical Trials

Bandebereho Father Groups Randomized Control Trial in Rwanda

Start date: February 2015
Phase: N/A
Study type: Interventional

This study seeks to assess the impact of the MenCare+/Bandebereho fathers'/couples' group education intervention on men's attitudes towards, and participation in, sexual and reproductive health, maternal, newborn and child health, and equitable and non-violent relationships with their children and partners.